Korea, Democratic People's Republic of vs Slovakia: Treatment success rate for patients treated for MDR-TB
Korea, Democratic People's Republic of
80.0%
in 2022
Slovakia
80.0%
in 2022
Korea, Democratic People's Republic of rank
50th
Slovakia rank
50th
Treatment success rate for patients treated for MDR-TB over time
- Korea, Democratic People's Republic of
- Slovakia
How they compare
Korea, Democratic People's Republic of currently reports 80.0% against 80.0% in Slovakia, a difference of 0.0%.
The two have swapped places 1 time across 11 shared years of data; in 2012 it was Korea, Democratic People's Republic of ahead.
Korea, Democratic People's Republic of ranks 50th and Slovakia ranks 50th of 163 countries.
Across the 2 decades both report, Korea, Democratic People's Republic of averaged higher in 1 and Slovakia in 1.
Head to head by decade
| Decade | Korea, Democratic People's Republic of | Slovakia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 79.9% | 33.8% | 46.1% | Korea, Democratic People's Republic of |
| 2020s | 76.7% | 86.7% | 10.0% | Slovakia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Korea, Democratic People's Republic of or Slovakia?
- Korea, Democratic People's Republic of, at 80.0% against 80.0% in Slovakia as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Korea, Democratic People's Republic of and Slovakia?
- 0.0%, with Korea, Democratic People's Republic of ahead.
- How many years of comparable data are there for Korea, Democratic People's Republic of and Slovakia?
- 11 years are reported by both, from 2012 to 2022.
- How do Korea, Democratic People's Republic of and Slovakia rank globally for treatment success rate for patients treated for mdr-tb?
- Korea, Democratic People's Republic of ranks 50th and Slovakia ranks 50th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.